Evidera
Balazs Peter is an experienced Associate Research Scientist at Evidera since September 2019, specializing in health economic modeling and proficient in Excel/VBA and R programming for healthcare intervention decision-making. Previously, Balazs served as a Scientific Associate at the National Public Health Institute in Hungary from June 2016 to August 2019, focusing on Health Impact Assessments related to air pollution, conducting literature reviews, and contributing to public health guidelines. Balazs also completed an internship at the National Health Insurance Fund of Hungary in early 2016, engaging in tasks related to medical device reimbursement processes and healthcare funding management. Academic credentials include a Master's Degree in Health Policy, Planning and Financing and Bachelor's degrees in Sociology and Public Administration Management from Eötvös Loránd University and Nemzeti Közszolgálati Egyetem, respectively.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.